News

Under terms of the definitive agreement, Healthscreen has agreed to pay a total of $1.3 million for Regent. The purchase price is payable in cash of $1 million

Previously, Aushon offered reverse phase array (RPA) print services through its custom microarray printing services, but has now added downstream array processing and data analysis. These RPA arrays

Under a 2007 agreement between the two companies, Micromet and Nycomed develop MT203, a fully human anti-GM-CSF antibody that may be useful for the treatment of various inflammatory

A total of 30 patients, with either single or two level degenerative disc disease, were implanted with the M6-C cervical disc. The study was completed at three participating

With this approval, the company is poised to move into the fast growing European market of partial knee replacements. Steve Ek, COO of Arthrosurface, said: “We have taken

The agreement provides Advanced Medical Optics (AMO) with paid-up, non-exclusive, worldwide licenses under a family of Alcon patents. The licenses are restricted to single piece intraocular lens’s (IOL)

Under the service contract, the University of British Columbia (UBC) will conduct research at the UBC Department of Medicine, and the Vancouver Coastal Health Research Institute, which conducts

In exchange, Pfizer has agreed to make an undisclosed payment to Melior and provide access to certain data it owns related to MLR-1023. In addition, Melior has agreed

Invitrogen’s Predictor hERG fluorescence polarization assay kit is said to be the first commercially available non-radioactive, homogenous assay kit for high-throughput screening of compounds interacting with the hERG